1. Phase II evaluation of Bleomycin;Haas;Cancer,1976
2. Bleomycin, an antitumor antibiotic;Yagoda;Ann Intern Med,1972
3. Treatment-related lung damage;Travis,1996
4. Quantification of bleomycin pulmonary toxicity in mice by changes in lung hydroxylproline content and morphometric histopathology;Sikic;Cancer Res,1978
5. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse;Haston;Cancer Res,1996